Sean Brynjelsen - Net Worth and Insider Trading
Sean Brynjelsen Net Worth
The estimated net worth of Sean Brynjelsen is at least $15 Million dollars as of 2025-01-14. Sean Brynjelsen is the CEO of Eton Pharmaceuticals Inc and owns about 1,064,940 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $15 Million. Details can be seen in Sean Brynjelsen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Brynjelsen has not made any transactions after 2022-09-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sean Brynjelsen
Sean Brynjelsen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean Brynjelsen owns 2 companies in total, including Eton Pharmaceuticals Inc (ETON) , and Sagent Pharmaceuticals Inc (SGNT) .
Click here to see the complete history of Sean Brynjelsen’s form 4 insider trades.
Insider Ownership Summary of Sean Brynjelsen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ETON | Eton Pharmaceuticals Inc | 2022-09-22 | director & President & CEO |
| SGNT | Sagent Pharmaceuticals Inc | 2016-08-29 | EVP & Business Development |
Sean Brynjelsen Latest Holdings Summary
Sean Brynjelsen currently owns a total of 1 stock. Sean Brynjelsen owns 1,064,940 shares of Eton Pharmaceuticals Inc (ETON) as of September 22, 2022, with a value of $15 Million.
Latest Holdings of Sean Brynjelsen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals Inc | 2022-09-22 | 1,064,940 | 14.00 | 14,909,160 |
Holding Weightings of Sean Brynjelsen
Sean Brynjelsen Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean Brynjelsen has made a total of 3 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 10,000 shares on September 22, 2022, which cost Sean Brynjelsen around $21,000.
Insider Trading History of Sean Brynjelsen
- 1
Sean Brynjelsen Trading Performance
GuruFocus tracks the stock performance after each of Sean Brynjelsen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean Brynjelsen is 0.86%. GuruFocus also compares Sean Brynjelsen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean Brynjelsen within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sean Brynjelsen's insider trading performs compared to the benchmark.
Performance of Sean Brynjelsen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0 | | | | | |
| Relative Return to S&P 500(%) | -0.47 | | | | | |
Sean Brynjelsen Ownership Network
Ownership Network List of Sean Brynjelsen
Ownership Network Relation of Sean Brynjelsen
Sean Brynjelsen Owned Company Details
What does Eton Pharmaceuticals Inc do?
Who are the key executives at Eton Pharmaceuticals Inc?
Sean Brynjelsen is the director & President & CEO of Eton Pharmaceuticals Inc. Other key executives at Eton Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , Chief Business Officer David Krempa , and Chief Financial Officer James R. Gruber .
Eton Pharmaceuticals Inc (ETON) Insider Trades Summary
Over the past 18 months, Sean Brynjelsen made no insider transaction in Eton Pharmaceuticals Inc (ETON). Other recent insider transactions involving Eton Pharmaceuticals Inc (ETON) include a net purchase of 179,570 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Eton Pharmaceuticals Inc (ETON) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Eton Pharmaceuticals Inc (ETON) were sold and 179,570 shares were bought by its insiders, resulting in a net purchase of 179,570 shares.
Eton Pharmaceuticals Inc (ETON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eton Pharmaceuticals Inc Insider Transactions
Sean Brynjelsen Mailing Address
Above is the net worth, insider trading, and ownership report for Sean Brynjelsen. You might contact Sean Brynjelsen via mailing address: C/o Eton Pharmaceuticals, Inc., 21925 W Field Pkwy #235, Deer Park Il 60010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
